Journals / Uluslararası Hematoloji-Onkoloji Dergisi / 2019 / Cilt: 29 - Sayı: 3

Rektum Kanserinde Neoadjuvan Radyoterapi Uygulamasında SIB (Simultaneous Integrated Boost) tekniği kullanarak Yoğunluk Ayarlı Radyoterapi (YART), Volumetrik Modulated Ark Terapi (VMAT) ve Helikal Tomoterapi (HT) yöntemlerinin Dozimetrik ve Integral D

Integral Dose and Dosimetric Comparison of NeoAdjuvant Simultaneous Integrated Boost (SIB) Radiotherapy Technique for Rectal Cancer Using Intensity-Modulated Radiotherapy (IMRT), Volumetric Modulated Arc Therapy (VMAT), and Helical Tomotherapy (HT)

Pages
147–156
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Pelvik tüm kemiklerde ortalama V10, V20, V30, V40, Dmean değeri HT ‘de daha yüksek bulunmuştur.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Bu çalışmanın amacı rektum kanserinde neoadjuvan radyoterapi uygulamasında SIB (Simultaneous Integrated Boost) tekniği kullanarak Yoğunluk Ayarlı Radyoterapi (YART), Volumetrik Modulated Ark Terapi (VMAT) ve Helikal Tomoterapi (HT) yöntemlerinin karşılaştırılmasıdır.
📊
Key Findings & Data:Bu çalışma için toplam 10 hasta randomize olarak seçildi.
💡
Conclusion & Impact:Pelvik tüm kemiklerde ortalama V10, V20, V30, V40, Dmean değeri HT ‘de daha yüksek bulunmuştur.
🔬Design:Experimental Field Trial
📍Scope:10 hasta
⚙️Variables:Domain Parameters

Abstract

Bu çalışmanın amacı rektum kanserinde neoadjuvan radyoterapi uygulamasında SIB (Simultaneous Integrated Boost) tekniği kullanarak Yoğunluk Ayarlı Radyoterapi (YART), Volumetrik Modulated Ark Terapi (VMAT) ve Helikal Tomoterapi (HT) yöntemlerinin karşılaştırılmasıdır. Bu çalışma için toplam 10 hasta randomize olarak seçildi. Her hasta için IMRT,VMAT ve HT olmak üzere 3 ayrı plan yapıldı. Simultaneous Integrated Boost (SIB) tekniği kullanılarak pelvik lenf nodlarına 45 Gy; rektum ve mezorektuma 50 Gy 25 fraksiyonda reçetelendirildi. PTV parametreleri, Integral doz, Doz volüm histogramları (DVH) ve risk altındaki organlar 3 ayrı planda değerlendirildi.PTV Dmax, Integral doz en düşük HT’de sağlanmıştır. D2 en az HT’de; D98 en yüksek HT’de bulunmuştur. Homojenite indeksi (HI) arasında fark bulunmazken konformite indeksi (CI) IMRT ve VMAT’da daha iyi bulunmuştur. Toplam MU ve ışınlama süreleri ise HT’de yüksek bulunmuştur. Riskli organlardan mesane en iyi HT’de, bağırsak 35 Gy alan hacim en az VMAT’da 45 Gy alan hacim ise IMRT’de sağlanmıştır. Sağlıklı doku 5 Gy ve 10 Gy alan hacim (cc) en çok HT’de, 20 Gy alan hacim (cc) ise IMRT ‘de yüksek bulunmuştur. Pelvik tüm kemiklerde ortalama V10, V20, V30, V40, Dmean değeri HT ‘de daha yüksek bulunmuştur.

Özet

The purpose of the present study is to compare the Intensity-Modulated Radiotherapy (IMRT), Volumetric Modulated Arc Therapy (VMAT), Helical Tomotherapy (HT) techniques in rectal cancer. A total of 10 patients, were randomly selected for this study. Three separate plans were made for each patient: IMRT, VMAT and HT. By using the Simultaneous Integrated Boost (SIB) technique, 45 Gy to pelvic lymph nodes, and 50 Gy 25 fractions were prescribed to the rectum and mesorectum. The PTV parameters, Integral dose, Dose Volume Histograms (DVH) and Organ at Risk were evaluated with 3 separate plans. The PTV Dmax, Integral dose was ensured at the lowest level in HT. The D2 was detected at the lowest level in HT, and at the highest level in D98. Although there was no difference between Homogeneity Indices (HI), Conformity Index (CI) was found to be better in IMRT and VMAT. The total MU and Beam on Time values were found to be high in HT. The bladder, which is one of the risky organs, was provided at the best level in HT, the volume in the bowel was provided in VMAT at the lowest level with 35 Gy, and the 45 Gy volume was provided in IMRT. The healthy tissue volume was 5 Gy and 10 Gy (cc) as the highest in HT, and 20 Gy volume (cc) was high in IMRT. The Mean V10, V20, V30, V40, Dmean values of the pelvic whole bones were higher in HT.

🔖

Cite This Article

TEMELLİ, Ö., DEMİRTAŞ, M., UĞURLU, B. T., BAĞ, H. G. (2019). Rektum Kanserinde Neoadjuvan Radyoterapi Uygulamasında SIB (Simultaneous Integrated Boost) tekniği kullanarak Yoğunluk Ayarlı Radyoterapi (YART), Volumetrik Modulated Ark Terapi (VMAT) ve Helikal Tomoterapi (HT) yöntemlerinin Dozimetrik ve Integral D. Uluslararası Hematoloji-Onkoloji Dergisi, Cilt: 29 - Sayı: 3, 147–156. https://ajindex.com/articles/322756

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin 65: 5-29, 2015
  2. Wang S, Hathout L, Malhotra U, et al. Decision-Making Strategy for rectal cancer management using radiation therapy for elderly or comorbid patients. Int J Radiat Oncol Biol Phys 100: 926-944, 2018
  3. Cilla S, Caravatta L, Picardi V, et al. Volumetric modulated arc therapy with simultaneous integrated boost for locally advanced rectal cancer. Clin Oncol 24: 261-268, 2012
  4. Reyngold M, Niland J, Veer A, et al. Trends in intensity modulated radiation therapy use for locally advanced rectal cancer at National Comprehensive Cancer Network centers. Adv Radiat Oncol 3: 34-41, 2018
  5. Guerrero Urbano MT, Henrys AJ, Adams EJ, et al. Intensitymodulated radiotherapy in patients with locally advanced rectal cancer reduces volume of bowel treated to high dose levels. Int J Radiat Oncol Biol Phys 65: 907-16, 2006
  6. Arbea L, Ramos L, Monge R.M, et al. Intensity-modulated radiation therapy (IMRT) vs. 3D conformal radiotherapy (3DCRT) in locally advanced rectal cancer (LARC): dosimetric comparison and clinical implications. Radiat Oncol 5: 17, 2010
  7. Dogan N, King S, Emami B, et al. Assessment of different IMRT boost delivery methods on target coverage and normak tissue sparing. Int J radiat Oncol Biol Phys 57: 1480-1491, 2003
  8. Engels B, Tournel K, Everaert H, et al. Phase II study of preoperative helical tomotherapy with a simultaneous integrated boost for rectal cancer. Int J Radiat Oncol Biol Phys 83: 142- 148, 2012
  9. Gani Z, Altundag I. Tomotherapy. Turkiye Klinikleri J Radiat Oncol-Special Topics 2: 157-62, 2016
  10. Myerson RJ, Garofalo MC, El Naqa I, et al. Elective clinical target volumes for conformal therapy in anorectal cancer: a radiation therapy oncology group consensus panel contouring atlas. Int J Radiat Oncol Biol Phys 74: 824-830, 2008
  11. Mell, Loren K. et al. Dosimetric predictors of acute hematologic toxicity in cervicalcancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy. International Journal of Radiation Oncol Biology Phys 66: 1356-1365, 2006
  12. Hong TS, Moughan J, Garofalo MC, et al. A phase 2 study of preoperative chemoradiation therapy using intensity modulated radiation therapy in combination with capecitabine and oxaliplatin for patients with locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 93: 29-36, 2015
  13. Kataria T, Sharma K, Subramani V, et al. Homogeneity Index: An objective